[Hemodilution, hemorheology and oxygen supply]

Area of Science:

• Rheology and Hemodynamics
• Ischemic Disease Pathophysiology
• Therapeutic Interventions

Context:

• Hemodilution therapy is a recognized treatment for improving tissue oxygenation in patients with ischemic conditions.
• Peripheral and retinal ischemic diseases have shown positive responses to hemodilution.
• Cerebral ischemia studies present contradictory results, necessitating further investigation.

Purpose:

• To review the efficacy of hemodilution in improving hemorheological properties and oxygen supply to ischemic tissues.
• To establish optimal hemodilution parameters, including hematocrit levels, for various ischemic conditions.
• To highlight the need for improved clinical study designs for cerebral ischemia treatment.

Summary:

• Hemodilution therapy enhances blood flow and tissue oxygenation in ischemic diseases.
• A hematocrit target of approximately 40% has been identified as a guideline for chronic arterial occlusive disease of the legs.
• Optimal hemodilution strategies must be experimentally determined for different conditions, such as cerebral ischemia, to ensure therapeutic success.

Impact:

• Provides a guideline hematocrit value for hemodilution in chronic leg arterial disease.
• Emphasizes the need for condition-specific hemodilution protocols, particularly for cerebral ischemia.
• Suggests that well-designed clinical studies with defined therapeutic modalities are crucial for advancing hemodilution therapy.